Human papillomavirus (HPV) prevalence was estimated from 2,705 sexually active, uncircumcised, human immunodeficiency virus seronegative men aged 17-28 years in Kisumu, Kenya. HPV prevalence was 51.1% (95% confidence interval: 49.2-53.0%) in penile cells from the glans/coronal sulcus and/or shaft. HPV prevalence varied by anatomical site, with 46.5% positivity in the glans/coronal sulcus compared with 19.1% in the shaft (p < 0.0001). High-risk HPV was detected in 31.2% of glans and 12.3% of shaft samples (p < 0.0001). HPV16 was the most common type and 29.2% of men were infected with more than one HPV type. Risk factors for HPV infection included presence of C. trachomatis, N. gonorrhea, self-reported sexually transmitted infections, and less frequent bathing. Lifetime number of sexual partners and herpes simplex virus type-2 seropositivity were also marginally associated with HPV infection.Human papillomavirus (HPV) infection is the main cause of invasive cervical cancer (ICC) in women, and an important cause of vaginal, vulvar and anal cancer in women as well as anal and penile cancer in men. Given that men are important in transmitting infection to their female partners, understanding factors associated with HPV infections in men are important for control of HPV infection in both men and women. HPV prevalence data in men are limited, especially from Africa, despite ICC being the most common female cancer in this region.1 Type-specific data in men are needed to improve understanding of factors associated with male HPV infection and the role of penile high-risk HPV (i.e., oncogenic) types in transmission to female partners.Few data are available comparing HPV type-distribution from different anatomical sites in men.2,3 Although risk factors for penile HPV infections in men have been reported, 4 data remain unreported on associations between penile HPV infection and laboratory-diagnosed sexually transmitted infections (STIs) including C. trachomatis and N. gonorrhea.We previously reported penile HPV prevalence in three anatomical sites (shaft; glans/coronal sulcus; and urethra) from 98 men in Kisumu, Kenya.5 Here we assess type-specific HPV prevalence by anatomical site and estimate risk factors for prevalent HPV infection in over 2,700 young sexually active, uncircumcised men in Kenya, including the 98 men reported on previously.
Material and Methods
Study Population and EnrollmentUncircumcised men aged 17-28 years were screened between February 4, 2002 and September 6, 2005 in Kisumu, Kenya to participate in a randomized controlled trial (RCT) of male circumcision. 6 The primary aim of the RCT was to determine the effectiveness of male circumcision in reducing human immunodeficiency virus (HIV) incidence. In brief, inclusion criteria included being uncircumcised, HIV seronegative, sexually active, and having hemoglobin of 9.0 g/100 mL. Study